Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia

Journal of Medical Virology

Volumn 84, Issue 5, 2012, Pages 768-776

  Hutajulu, Susanna Hilda ^a   Ng, Nawi ^b   Jati, Baning Rahayu ^a   Fachiroh, Jajah ^a   Herdini, Camelia ^a   Hariwiyanto, Bambang ^a   Haryana, Sofia Mubarika ^a   Middeldorp, Jaap Michiel ^c  

^a GADJAH MADA UNIVERSITY   (Indonesia)

^b UMEÅ UNIVERSITY   (Sweden)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Family members; IgA anti EBV ELISA; Sporadic case of nasopharyngeal carcinoma

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FATHER; FEMALE; HUMAN; HUMAN TISSUE; INDONESIA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; RELATIVE; SIBLING;

ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FAMILY; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; INDONESIA; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RISK FACTORS; YOUNG ADULT;

HUMAN HERPESVIRUS 4;

EID: 84858593964     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23263     Document Type: Article

References (75)

1. Armstrong RW, Eng AC. 1983. Salted fish and nasopharyngeal carcinoma in Malaysia. Soc Sci Med 17: 1559- 1567.
2. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. 1998. Nasopharyngeal carcinoma in Malaysian Chinese: Salted fish and other dietary exposures. Int J Cancer 77: 228- 235.
3. Cao SM, Liu Z, Jia WH, Huang QH, Liu Q, Guo X, Huang TB, Ye W, Hong MH. 2011. Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: A prospective screening study with a 20-year follow-up. PLoS One 6: e19100.
4. Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. 1991. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes Control 2: 125- 131.
5. Chang ET, Adami HO. 2006. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1765- 1777.
6. Chen DL, Huang TB. 1997. A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett 117: 17- 22.
7. Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee HH, Kuo SL, Yang CS. 1985. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol 17: 47- 49.
8. Chen JY, Chen CJ, Liu MY, Cho SM, Hsu MM, Lynn TC, Shieh T, Tu SM, Beasley RP, Hwang LY. 1989. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 27: 269- 273.
9. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY. 1990. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 10: 547- 553.
10. Chen CS, Pignatelli B, Malaveille C, Bouvier G, Shuker D, Hautefeuille A, Zhang RF, Bartsch H. 1992. Levels of direct-acting mutagens, total N-nitroso compounds in nitrosated fermented fish products, consumed in a high-risk area for gastric cancer in southern China. Mutat Res 265: 211- 221.
11. Chen L, Gallicchio L, Boyd-Lindsley K, Tao XG, Robinson KA, Lam TK, Herman JG, Caulfield LE, Guallar E, Alberg AJ. 2009. Alcohol consumption and the risk of nasopharyngeal carcinoma: A systematic review. Nutr Cancer 61: 1- 15.
12. Cheng YC, Chen JY, Glaser R, Henle W. 1980. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma. Proc Natl Acad Sci USA 77: 6162- 6165.
13. Cheng YJ, Hildesheim A, Hsu MM, Chen IH, Brinton LA, Levine PH, Chen CJ, Yang CS. 1999. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 10: 201- 207.
14. Cheng J, Cai Y, Zheng Y, Li J, Mo Y. 2009. Analysis of serum levels of IgA antibodies to Epstein-Barr virus capsid antigens in the spouses and the children of patients with nasopharyngeal carcinoma. Clin Oncol Cancer Res 6: 267- 270.
15. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS. 2001. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345: 1877- 1882.
16. Chow WH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ. 1993. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer 55: 538- 540.
17. Coskun O, Sener K, Kilic S, Erdem H, Yaman H, Besirbellioglu AB, Gul HC, Eyigun EP. 2010. Stress-related Epstein-Barr virus reactivation. Clin Exp Med 10: 15- 20.
18. Dolken G, Weitzmann U, Boldt C, Bitzer M, Brugger W, Lohr GW. 1984. Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISA. J Immunol Meth 68: 331- 339.
19. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM. 2006. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: Options for field screening. J Clin Microbiol 44: 1459- 1467.
20. Fachiroh J, Prasetyanti PR, Paramita DK, Prasetyawati AT, Anggrahini DW, Haryana SM, Middeldorp JM. 2008. Dried-blood sampling for Epstein-Barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening. J Clin Microbiol 46: 1374- 1380.
21. Feng BJ, Khyatti M, Ben-Ayoub W, Dahmoul S, Ayad M, Maachi F, Bedadra W, Abdoun M, Mesli S, Bakkali H, Jalbout M, Hamdi-Cherif M, Boualga K, Bouaouina N, Chouchane L, Benider A, Ben-Ayed F, Goldgar DE, Corbex M. 2009. Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer 101: 1207- 1212.
22. Friborg J, Wohlfahrt J, Koch A, Storm H, Olsen OR, Melbye M. 2005. Cancer susceptibility in nasopharyngeal carcinoma families-A population-based cohort study. Cancer Res 65: 8567- 8572.
23. Friborg J, Jarrett RF, Liu MY, Falk KI, Koch A, Olsen OR, Duncan P, Wohlfarht J, Chen JY, Melbye M. 2007. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland. J Med Virol 79: 1877- 1881.
24. Gallicchio L, Matanoski G, Tao XG, Chen L, Lam TK, Boyd K, Robinson KA, Balick L, Mickelson S, Caulfield LE, Herman JG, Guallar E, Alberg AJ. 2006. Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: A systematic review. Int J Cancer 119: 1125- 1135.
25. Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, Chen M, Yeh PE, Klimas NG, Marshall GD, Whiteside T, Herberman R, Kiecolt-Glaser J, Williams MV. 2005. Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: Implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19: 91- 103.
26. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600- 1608.
27. Henle G, Henle W. 1976. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17: 1- 7.
28. Hildesheim A, Levine PH. 1993. Etiology of nasopharyngeal carcinoma: A review. Epidemiol Rev 15: 466- 485.
29. Hildesheim A, West S, DeVeyra E, De Guzman MF, Jurado A, Jones C, Imai J, Hinuma Y. 1992. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Cancer Res 52: 3048- 3051.
30. Hildesheim A, Dosemeci M, Chan CC, Chen CJ, Cheng YJ, Hsu MM, Chen IH, Mittl BF, Sun B, Levine PH, Chen JY, Brinton LA, Yang CS. 2001. Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 10: 1145- 1153.
31. Ho JH. 1972. Nasopharyngeal carcinoma (NPC). Adv Cancer Res 15: 57- 92.
32. Ho HC, Ng MH, Kwan HC. 1978. Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma. Br J Cancer 37: 356- 362.
33. Hsu WL, Yu KJ, Chien YC, Chiang CJ, Cheng YJ, Chen JY, Liu MY, Chou SP, You SL, Hsu MM, Lou PJ, Wang CP, Hong JH, Leu YS, Tsai MH, Su MC, Tsai ST, Chao WY, Ger LP, Chen PR, Yang CS, Hildesheim A, Diehl SR, Chen CJ. 2011. Familial tendency and risk of nasopharyngeal carcinoma in taiwan: Effects of covariates on risk. Am J Epidemiol 173: 292- 299.
34. Ireland B, Lanier AP, Knutson L, Clift SE, Harpster A. 1988. Increased risk of cancer in siblings of Alaskan native patients with nasopharyngeal carcinoma. Int J Epidemiol 17: 509- 511.
35. Ji MF, Wang DK, Yu YL, Guo YQ, Liang JS, Cheng WM, Zong YS, Chan KH, Ng SP, Wei WI, Chua DT, Sham JS, Ng MH. 2007. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer 96: 623- 630.
36. Ji X, Zhang W, Xie C, Wang B, Zhang G, Zhou F. 2011. Nasopharyngeal carcinoma risk by histologic type in central China: Impact of smoking, alcohol and family history. Int J Cancer 129: 724- 732.
37. Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX, Liu WS, Qin HD, Feng QS, Chen LZ, Yao SY, Zeng YX. 2010. Traditional Cantonese diet and nasopharyngeal carcinoma risk: A large-scale case-control study in Guangdong, China. BMC Cancer 10: 446.
38. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL, Lau WH. 2005. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107- 1116.
39. Lee YC, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J, Lazarus P, Matos E, Hayes RB, Winn DM, Zaridze D, Wunsch-Filho V, Eluf-Neto J, Koifman S, Mates D, Curado MP, Menezes A, Fernandez L, Daudt AW, Szeszenia-Dabrowska N, Fabianova E, Rudnai P, Ferro G, Berthiller J, Brennan P, Hashibe M. 2008. Involuntary smoking and head and neck cancer risk: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 17: 1974- 1981.
40. Li S, Deng Y, Li X, Chen QP, Liao XC, Qin X. 2010. Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma: A meta-analysis. Chin Med J (Engl) 123: 1201- 1205.
41. Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ. 2003. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45: 1- 36.
42. Nam JM, McLaughlin JK, Blot WJ. 1992. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: A case-control study among U.S. whites. J Natl Cancer Inst 84: 619- 622.
43. Nesic V, Sipetic S, Vlajinac H, Stosic-Divjak S, Jesic S. 2010. Risk factors for the occurrence of undifferentiated carcinoma of nasopharyngeal type: A case-control study. Srp Arh Celok Lek 138: 6- 10.
44. Ng WT, Yau TK, Yung RW, Sze WM, Tsang AH, Law AL, Lee AW. 2005. Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 113: 998- 1001.
45. Ng WT, Choi CW, Lee MC, Law LY, Yau TK, Lee AW. 2009. Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong. Fam Cancer 9: 221- 228.
46. Ning JP, Yu MC, Wang QS, Henderson BE. 1990. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst 82: 291- 296.
47. Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM. 2009. Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma. Clin Vaccine Immunol 16: 706- 711.
48. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55: 74- 108.
49. Pickard A, Chen CJ, Diehl SR, Liu MY, Cheng YJ, Hsu WL, Sun B, Hsu MM, Chen IH, Chen JY, Yang CS, Mittl BL, Chou SP, Ruggles DD, Goldstein AM, Hildesheim A. 2004. Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan. Int J Cancer 111: 117- 123.
50. Poirier S, Ohshima H, de-The G, Hubert A, Bourgade MC, Bartsch H. 1987. Volatile nitrosamine levels in common foods from Tunisia, south China and Greenland, high-risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 39: 293- 296.
51. Poirier S, Bouvier G, Malaveille C, Ohshima H, Shao YM, Hubert A, Zeng Y, de The G, Bartsch H. 1989. Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation. Int J Cancer 44: 1088- 1094.
52. Qin HD, Jia WH, Zhang LL, Liu N, Zhou XX, Wang MH, Feng QS, Chen LZ, Zhang Y, Jorgensen TJ, Zeng YX, Shugart YY. 2011. Elevated Epstein-Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma. J Med Virol 83: 1792- 1798.
53. Raab-Traub N. 1992. Epstein-Barr virus infection in nasopharyngeal carcinoma. Infect Agents Dis 1: 173- 184.
54. Schuurs AH, Verheul HA. 1990. Effects of gender and sex steroids on the immune response. J Steroid Biochem 35: 157- 172.
55. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Talaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens-Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10: 1033- 1034.
56. Shao YM, Poirier S, Ohshima H, Malaveille C, Zeng Y, de The G, Bartsch H. 1988. Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma. Carcinogenesis 9: 1455- 1457.
57. Soeripto 1998. Epidemiology of nasopharyngeal carcinoma. Berita Kedokt Masyarakat (Ina) XIII: 207- 211.
58. Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. 1992. Environmental risk factors for nasopharyngeal carcinoma: A case-control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev 1: 345- 348.
59. Ung A, Chen CJ, Levine PH, Cheng YJ, Brinton LA, Chen IH, Goldstein AM, Hsu MM, Chhabra SK, Chen JY, Apple RJ, Yang CS, Hildesheim A. 1999. Familial and sporadic cases of nasopharyngeal carcinoma in Taiwan. Anticancer Res 19: 661- 665.
60. Wagner HJ, Hornef M, Teichert HM, Kirchner H. 1994. Sex difference in the serostatus of adults to the Epstein-Barr virus. Immunobiology 190: 424- 429.
61. West S, Hildesheim A, Dosemeci M. 1993. Non-viral risk factors for nasopharyngeal carcinoma in the Philippines: Results from a case-control study. Int J Cancer 55: 722- 727.
62. Yang XR, Diehl S, Pfeiffer R, Chen CJ, Hsu WL, Dosemeci M, Cheng YJ, Sun B, Goldstein AM, Hildesheim A. 2005. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 14: 900- 905.
63. Yu MC, Ho JH, Lai SH, Henderson BE. 1986. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: Report of a case-control study in Hong Kong. Cancer Res 46: 956- 961.
64. Yu MC, Huang TB, Henderson BE. 1989a. Diet and nasopharyngeal carcinoma: A case-control study in Guangzhou, China. Int J Cancer 43: 1077- 1082.
65. Yu MC, Nichols PW, Zou XN, Estes J, Henderson BE. 1989b. Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish. Br J Cancer 60: 198- 201.
66. Yu MC, Garabrant DH, Huang TB, Henderson BE. 1990. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 45: 1033- 1039.
67. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. 2000a. Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 85: 364- 369.
68. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. 2000b. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 85: 358- 363.
69. Zeng Y, Zhang LG, Li HY, Jan MG, Zhang Q, Wu YC, Wang YS, Su GR. 1982. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 29: 139- 141.
70. Zeng J, Gong CH, Jan MG, Fun Z, Zhang LG, Li HY. 1983. Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography. Int J Cancer 31: 599- 601.
71. Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JY, Wang YB, Jiang MK, Fang Z, Meng NN. 1985. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 36: 545- 547.
72. Zheng X, Yan L, Nilsson B, Eklund G, Drettner B. 1994a. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 33: 867- 872.
73. Zheng YM, Tuppin P, Hubert A, Jeannel D, Pan YJ, Zeng Y, de The G. 1994b. Environmental and dietary risk factors for nasopharyngeal carcinoma: A case-control study in Zangwu County, Guangxi, China. Br J Cancer 69: 508- 514.
74. Zou J, Sun Q, Akiba S, Yuan Y, Zha Y, Tao Z, Wei L, Sugahara T. 2000. A case-control study of nasopharyngeal carcinoma in the high background radiation areas of Yangjiang, China. J Radiat Res (Tokyo) 41: 53- 62.
75. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. 1970. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056- 1058.